You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Research Articles
Popular Research Articles
Highly Recommended Research Articles
Send a link to this page to your friends and colleagues.
The device uses polytetrafluoroethylene to encase and protect transplanted pancreatic precursor cells from attacks by T-cells, the "soldiers" of the body's immune system. By protecting the transplanted cells from T-cell assaults, the device could do away with the need for type 1 transplant patients to take long-term immunosuppressant drugs.
A study on mice conducted by the Burnham Institute for Medical Research and the University of California, San Diego, School of Medicine, both located in La Jolla, California, found that precursor cells encapsulated in the plastic device generated no response by the immune system.\
The scientists originally thought that even though the T-cells would not be able to penetrate the protective casing, they would cluster around it like an army laying siege to a well-fortified town. Instead, T-cells ignored the intruder, indicating that the immune system was not even aware of the presence of the device.
Precursor cells are cells that have the potential to grow into cells that have more specific purposes-such as the production of insulin. The study found that such cells increased the likelihood of transplant success versus already formed pancreatic beta cells.
Although there have been many instances of successful transplantation of insulin-producing beta cells into animals and people with type 1 diabetes, the vexing problem is the inevitable immune system attack on the cells. Aside from the irony that type 1 diabetes is itself classified as an immune system disease, the long-term use of immunosuppressants to prevent attacks on the transplanted cells lowers patients' resistance to other diseases.
The San Diego researchers, who published their findings in the online journal Transplantation, say that encapsulation in a protective coating offers a potential new approach to treating type 1 diabetes. Instead of virtually eliminating a patient's immune system through heavy drugging, such devices could "hide" transplanted cells and offer a stealthy way to get them past the body's sentries.
2 comments - May 20, 2009
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.